ライフサイエンスコーパス: galactomannan

1 s were studied for expression of circulating galactomannan.

2 n on uniaxial extensions with glucomannan or galactomannan.

3 out on composites containing glucomannan or galactomannan.

4 production of galactosaminogalactan but not galactomannan.

5 us was no longer able to grow on locust bean galactomannan.

6 on of diagnostic tests based on detection of galactomannan.

7 time curves (AUCs) to achieve suppression of galactomannan.

8 in a polymer of mannose and galactose called galactomannan.

9 model for the flow of carbon from sucrose to galactomannans.

10 Galactomannans [(1-->6)-alpha-D-galactose (Gal)-substitu

11 We compared the diagnostic performances of galactomannan, 1,3-beta-D-glucan, and Aspergillus-specif

12 that makes the beta-1, 4-mannan backbone of galactomannan, a hemicellulosic storage polysaccharide i

13 this antibiotic will demonstrate circulating galactomannan above the threshold considered positive fo

14 re or positive bronchoalvelolar lavage (BAL) galactomannan after transplantation were classified as h

15 ella foenumgraecum) enzyme that has in vitro galactomannan alpha-1,6-galactosyltransferase activity.

16 retion factor and observing the secretion of galactomannan alpha-galactosyltransferase activity.

17 Galactomannan and (1 --> 3)-beta-D-glucan were also meas

18 Galactomannan and (1-->3)-beta-d-glucan assays were not

19 We assessed the performance of galactomannan and (1-->3)-beta-d-glucan in 29 serum samp

20 Galactomannan and beta-d-glucan detection were evaluated

21 The combination of WB PCR with galactomannan and beta-d-glucan proved optimal (area und

22 the earliest indicator of IA, and increasing galactomannan and beta-d-glucan values were indicators o

23 s of the galactofuranose (Galf) component of galactomannan and contributes galactose to the synthesis

24 e LFD test for IPA diagnosis (established by galactomannan and culture results) by using bronchoalveo

25 ns two galactose-containing polysaccharides, galactomannan and galactosaminogalactan, whose biosynthe

26 including O-glycans, N-glycans, fungal-type galactomannan and glycosylinositolphosphoceramide, which

27 ctions imply that Galbeta1,3-is added to the galactomannans and is then pyruvylated in situ, rather t

28 overall sensitivities for WB PCR, serum PCR, galactomannan, and beta-d-glucan were 73%, 65%, 68%, and

29 apsular polysaccharide, histoplasma antigen, galactomannan, and beta-d-glucan, is viewed as being cli

30 It does not bind to xylan, galactomannan, and carboxymethyl cellulose.

31 eceiving piperacillin-tazobactam circulating galactomannan antigen accumulates in vivo to significant

32 The utility of galactomannan antigen for diagnosing invasive aspergillo

33 ctam expressed a distinctively high level of galactomannan antigen in vitro (P = 0.001).

34 n-tazobactam contains significant amounts of galactomannan antigen in vitro, that in animals receivin

35 itated by assays that can detect Aspergillus galactomannan antigen or DNA in BAL fluid.

36 detecting fungi; microscopy, fungal culture, galactomannan antigen, and aspergillus PCR are useful te

37 to probable or proven mold disease based on galactomannan antigen, culture or histology; or remained

38 residual fungal burden (P</=.05), and serum galactomannan antigenemia (P</=.01), compared with eithe

39 Residual fungal pulmonary burden and galactomannan antigenemia demonstrated persistent infect

40 Glucuronoarabinoxylan, xyloglucan, and galactomannan are noncellulosic polysaccharides found in

41 Galactomannans are hemicellulosic polysaccharides compos

42 sperm, which accumulates large quantities of galactomannans as a reserve carbohydrate during seed dev

43 The galactomannan assay (GM), a non-culture-based surrogate

44 The presence of a positive serum galactomannan assay (SGM+) has also been associated with

45 Positivity rates for the galactomannan assay in serum and bronchoalveolar lavage

46 diagnostic tests (e.g. serum beta glucan and galactomannan assays), and the recent introduction of mo

47 ed a dramatic decrease in kcat against carob galactomannan, azo-carob galactomannan, mannotetraose an

48 here as a model system to better understand galactomannan biosynthesis and its regulation.

49 ctose substitution of the primary product of galactomannan biosynthesis appear to be regulated by the

50 Galactomannan biosynthesis in vitro is catalysed by memb

51 we identified genes known to be involved in galactomannan biosynthesis, as well as new genes that ma

52 To identify additional genes involved in galactomannan biosynthesis, we previously performed deep

53 Wall proteins, galactomannan, chitin, and beta-glucan are not the relev

54 Galactomannans comprise a beta-1,4-mannan backbone subst

55 gnostic odd ratios differed markedly between galactomannan (cut-off 0.5: optical density index, 0.97,

56 oven IA cases, as well as concordant PCR and galactomannan data in matched broncho-alveolar lavage an

57 The galactomannan Davanat(R) was more active, albeit not a s

58 Dialysate tested negative for galactomannan, demonstrating the inability of treatments

59 fore, at the beginning of, and during active galactomannan deposition.

60 azobactam who were found to have circulating galactomannan detected by the double sandwich enzyme-lin

61 Galactomannan detection in bronchoalveolar lavage (BAL)

62 We also prospectively collected data on all galactomannan EIAs performed between 1 September 2003 an

63 this property of piperacillin-tazobactam and galactomannan ELISA is not well understood, we investiga

64 l and spiked sera were blinded and sent with galactomannan enzyme immunoassay (EIA) kits to the parti

65 s studies have reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a usefu

66 ized and compared the diagnostic yields of a galactomannan enzyme immunoassay (GM EIA), quantitative

67 We evaluated the performance of a galactomannan enzyme immunoassay (GM EIA; Bio-Rad) by us

68 inical information available on inclusion of galactomannan enzyme immunoassay (GM-EIA) (2002) and bet

69 The galactomannan enzyme immunoassay (GM-EIA) is widely util

70 or use in fungal diagnostics, differences in galactomannan enzyme immunoassay (GM-EIA) performance ha

71 gated hepatitis B virus (HBV) antibodies and galactomannan enzyme immunoassay (GM-EIA) positivity.

72 The Platelia galactomannan enzyme immunoassay is a commercially avail

73 mance was comparable to that of both PCR and galactomannan enzyme immunoassay.

74 eported studies evaluating commercial tests (galactomannan enzyme-linked immunosorbent assay).

75 Transglycosylation of galactomannan from the membrane to the cell wall is hypo

76 ycosyltransferases, mannan synthase (MS) and galactomannan galactosyltransferase (GMGT).

77 The utility of Aspergillus galactomannan (GM) and beta-D-glucan (BG) in liver trans

78 In adults, the combination of galactomannan (GM) and fungal DNA detection has proven t

79 dies to assess the diagnostic performance of galactomannan (GM) and polymerase chain reaction (PCR) a

80 new methods of Aspergillus detection-sputum galactomannan (GM) and real-time PCR-alongside establish

81 lia Aspergillus enzyme immunoassay (EIA) for galactomannan (GM) antigen detection in bronchoalveolar

82 conate was the factor causing false-positive galactomannan (GM) antigenemia of Plasma-Lyte hydration

83 The benefit of the combination of serum galactomannan (GM) assay and polymerase chain reaction (

84 to investigate the performance of the serum galactomannan (GM) assay in hematology patients with a p

85 were comparable in sensitivity to BAL fluid galactomannan (GM) assay.

86 l-time PCR (targeting the 28S rRNA gene) and galactomannan (GM) detection when testing serum from a E

87 Previous studies have reported that galactomannan (GM) enzyme immunoassay and 1,3 beta-gluca

88 of bronchoalveolar lavage (BAL) in detecting galactomannan (GM) for diagnosing pulmonary aspergillosi

89 MY (Norman, OK) for detection of Histoplasma galactomannan (GM) in urine using an enzyme immunoassay

90 Prognostic features of serum galactomannan (GM) remain poorly defined in patients wit

91 , quantitative real-time PCR (qPCR), and the galactomannan (GM) test were used with 32 BAL fluid samp

92 eview the experience at our institution with galactomannan (GM) testing of bronchoalveolar lavage (BA

93 Galactomannan (GM) testing of urine specimens may provid

94 We hypothesize that galactomannan (GM), a component of fungal cell wall, as

95 reviewed and analyzed the available data for galactomannan (GM), beta-D-glucan (BG), and polymerase c

96 immunoassay (EIA), due to contamination with galactomannan (GM).

97 harides, such as modified citrus pectins and galactomannans, have been shown to have promising anti-i

98 Our findings suggest that the Platelia galactomannan immunoassay has good reproducibility.

99 this study was to determine the stability of galactomannan in clinical specimens stored at -20 degree

100 We first verified the specific deposition of galactomannans in developing endosperms and determined t

101 are known to accumulate large quantities of galactomannans in the endosperm, and were thus used here

102 gum and the discrimination between different galactomannans in the isolated polysaccharide fraction.

103 systems from transgenic seed endosperms form galactomannans in vitro that are more highly Gal substit

104 eracillin-tazobactam into rabbits, the serum galactomannan index (GMI) in vivo changed significantly

105 ative patient specimens showed no decline in galactomannan index (GMI) over 11 months at -20 degrees

106 sion were used to correlate early changes in galactomannan index (GMI) to mortality and overall respo

107 ensitivity; specifically, a low (0.5 to 0.7) galactomannan index (GMI) value to determine positivity

108 tween serum and bronchoalveolar lavage (BAL) galactomannan index (GMI) values and mortality in alloge

109 ys from the first positive serum Aspergillus galactomannan index (s-GMI).

110 The height of the serum galactomannan index predicts mortality.

111 ion, leukopenia, and the height of the serum galactomannan index were associated with an increased ri

112 aspergillosis and paradoxically rising serum galactomannan levels in the presence of chronic renal fa

113 enal failure and aspergillosis, rising serum galactomannan levels may not necessarily signify progres

114 Galactomannan levels were inextricably tied to fungal in

115 kcat against carob galactomannan, azo-carob galactomannan, mannotetraose and 2,4-dinitrophenyl beta-

116 asma antigen-negative and the 32 Aspergillus galactomannan-negative patients varied, but we were unab

117 han or equal to 5 acted as acceptors, as did galactomannans of low to medium galactose-substitution.

118 The N-linked galactomannans of Schizosaccharomyces pombe have pyruvyl

119 on sera that had been tested for Aspergillus galactomannan or Histoplasma antigen.

120 Positive galactomannan or suggestive signs triggered mandatory ev

121 ed in A. thaliana in degradation of mannans, galactomannans, or glucogalactomannans.

122 n-positive patients and 31 of 32 Aspergillus galactomannan-positive patients were also BG positive.

123 Galactomannan positivity correlated with mortality, even

124 Whether galactomannan positivity identifies a subgroup at risk f

125 blished by radiographic findings and maximum galactomannan positivity.

126 This indicates that the biosynthesis of galactomannan probably occurs in the lumen of the Golgi

127 oMan26B initially acts on the polysaccharide galactomannan, producing comparably large oligosaccharid

128 Data indicating that galactomannan remains stable when frozen are scant.

129 nosis of aspergillosis based on detection of galactomannan requires the use of clinical specimens tha

130 radicle emergence, whereas LeMAN1 mobilizes galactomannan reserves in the lateral endosperm.

131 GmtA leads to the absence of galactofuran or galactomannan, respectively.

132 data, we integrated the results of baseline galactomannan serum levels obtained from 249 (65.7%) fro

133 evice seems to be a promising alternative to galactomannan testing, which remains the diagnostic gold

134 inant HhMAN1 protein hydrolyzes coffee berry galactomannan, the major storage polysaccharide in this

135 days resulted in accumulation of circulating galactomannan to a mean peak GMI of 1.31 and a nadir of

136 e regression analysis suggested that maximum galactomannan value, Karnofsky score, and baseline plate

137 Serum galactomannan was assayed twice weekly for 60 days, then

138 Galactomannan was used as a biomarker.

139 Galactomannan was used to measure the antifungal effect

140 ition to being used to differentiate between galactomannans, was developed into a selective, quantita

141 tion:MIC values that achieved suppression of galactomannan were 1.68 and 1, respectively.

142 AUC:MIC values that achieved suppression of galactomannan were 55 and 32.1, respectively.

143 s of culture, polymerase chain reaction, and galactomannan were determined.

144 the side chains and backbone of pectins and galactomannans were additionally tested.

145 ackbone synthesis and side-chain addition of galactomannans were previously identified and characteri

146 tion characteristics of arabinogalactans and galactomannans were recovered in all fractions.

147 BoMan26B had higher activity on galactomannan with a high degree of galactosyl substitut

148 enugreek (Trigonella foenum-graecum) forms a galactomannan with a very high degree of Gal substitutio

149 bacco (Nicotiana tabacum) seed are rich in a galactomannan with a very low degree of Gal substitution

150 tively in membrane-bound form have endosperm galactomannans with increased average degrees of Gal sub